Comanche Biopharma

Concord, MA · Founded 2020 · Privately Held (backing)

Operator of a biopharmaceutical company intended to develop an investigational siRNA medicine for preterm preeclampsia. Comanche Biopharma is based in Concord, MA and was founded in 2020. It was valued at $210 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $136 million across 2 recorded rounds; the latest was a $37.5 million early-stage round in Dec 2023.

PMV mark · valuation
$210.0M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$136.1M
Last round
Early Stage VC
Dec 2023
How much has Comanche Biopharma raised?
$136.1Macross 2 recorded rounds · Jun 2021 – Dec 2023

Most recently, Comanche Biopharma raised $37.5M in its Early Stage VC (Dec 2023).

Free account
More of Comanche Biopharma with a free account
  • ·Watch Comanche Biopharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Comanche Biopharma round by round

2 rounds
Dec 2023Early Stage VC$37.5MSEC filing▮
7 investors participated
Jun 2021Early Stage VC$36.1MSEC filing▮
7 investors participated

How much has Comanche Biopharma raised?

Comanche Biopharma has raised $136 million in total; 2 of its rounds are on record. The largest on record was a $37.5 million early-stage round in Dec 2023.

Comanche Biopharma has filed 2 Form Ds with the SEC since 2023, most recently in Jan 2024 ($37.5 million sold to 7 investors).

Comanche Biopharma investors

8 investors are on record for Comanche Biopharma, including GV, New Enterprise Associates, F-Prime Capital and Atlas Venture. The early-stage round in Dec 2023 drew 7 investors.

For fundraisers
Raising for a company like Comanche Biopharma?

8 investors have backed Comanche Biopharma.

See all 8 investors →

Frequently asked about Comanche Biopharma

How much has Comanche Biopharma raised?
Comanche Biopharma has raised $136.1M in total across 2 recorded funding rounds.
When was Comanche Biopharma's last funding round?
Comanche Biopharma's most recent recorded round was Early Stage VC in Dec 2023, raising $37.5M.